TIAM
GOSS icon

TT International Asset Management’s Gossamer Bio GOSS Stock Holding History

TT International Asset Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-75,000
Closed -$693 – 75
2021
Q1 		$693 Buy
+75,000
New +$756K 0.03% 55

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

TT International Asset Management's GOSS Position: Q2 2021 in Review

TT International Asset Management sold out of Gossamer Bio (GOSS) in Q2 2021, closing a stake of 75,000 shares — an estimated $693 sold.

TT International Asset Management first reported a position in GOSS in Q1 2021 and held it in 1 quarter. The position peaked at $693 in Q1 2021. 115 funds tracked by Wall St. Rank hold GOSS as of Q2 2021.

  • TT International Asset Management reported no remaining Gossamer Bio position as of Q2 2021 after selling out during the quarter.
  • TT International Asset Management sold 75,000 Gossamer Bio shares in Q2 2021, an estimated $693.
  • TT International Asset Management first reported a position in Gossamer Bio in Q1 2021 and held it in 1 quarter.
  • TT International Asset Management's Gossamer Bio position peaked at $693 in Q1 2021.
  • 115 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2021.

Based on TT International Asset Management's 13F filing for Q2 2021, filed 6 Aug 2021.